Literature DB >> 24357348

Useful tests for hepatic encephalopathy in clinical practice.

Eiman Nabi1, Jasmohan S Bajaj.   

Abstract

Hepatic encephalopathy (HE) is a serious complication of liver disease and portosystemic shunting that represents a continuum of neuropsychiatric changes and altered consciousness. It is classified as overt HE (OHE) when clinically apparent or as covert HE (CHE) in its mildest form. Progression of CHE to OHE and its impact of quality of life make its early diagnosis imperative. Several diagnostic techniques ranging from simple clinical scales to sophisticated computerized tests exist, yet diagnosis remains a challenge, due to the time, cost, and personnel involved. Psychometric tests appear promising due to their high sensitivity and low cost, but results are variable depending on age and education. The pros and cons of current diagnostic methods for OHE and CHE are reviewed, along with strategy for CHE testing.

Entities:  

Mesh:

Year:  2014        PMID: 24357348      PMCID: PMC3918211          DOI: 10.1007/s11894-013-0362-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  62 in total

Review 1.  Hepatic encephalopathy.

Authors:  Vandana Khungar; Fred Poordad
Journal:  Clin Liver Dis       Date:  2012-05       Impact factor: 6.126

Review 2.  Assessment and usefulness of clinical scales for semiquantification of overt hepatic encephalopathy.

Authors:  Maiko Sakamoto; William Perry; Robin C Hilsabeck; Fatma Barakat; Tarek Hassanein
Journal:  Clin Liver Dis       Date:  2012-02       Impact factor: 6.126

Review 3.  New perspectives in hepatic encephalopathy.

Authors:  Kevin D Mullen; Ravi K Prakash
Journal:  Clin Liver Dis       Date:  2012-01-16       Impact factor: 6.126

4.  Is poor quality of life always present with minimal hepatic encephalopathy?

Authors:  Ravi K Prakash; Kevin D Mullen
Journal:  Liver Int       Date:  2011-04-11       Impact factor: 5.828

5.  Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy.

Authors:  Sara Montagnese; Sami Schiff; Matteo Turco; Carlo Alberto Bonato; Lorenzo Ridola; Angelo Gatta; Jean-Baptiste Nousbaum; Oliviero Riggio; Carlo Merkel; Piero Amodio
Journal:  Dig Liver Dis       Date:  2012-07-20       Impact factor: 4.088

6.  Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2011-04-12       Impact factor: 3.584

7.  Modified-orientation log to assess hepatic encephalopathy.

Authors:  M Salam; S Matherly; I S Farooq; R T Stravitz; R K Sterling; A J Sanyal; D P Gibson; J B Wade; L R Thacker; D M Heuman; M Fuchs; P Puri; V Luketic; S J Bickston; J S Bajaj
Journal:  Aliment Pharmacol Ther       Date:  2012-02-21       Impact factor: 8.171

8.  How to diagnose hepatic encephalopathy in the emergency department.

Authors:  Felix Gundling; Edin Zelihic; Holger Seidl; Bernhard Haller; Andreas Umgelter; Wolfgang Schepp; Christoph Dodt
Journal:  Ann Hepatol       Date:  2013 Jan-Feb       Impact factor: 2.400

9.  The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Michael Fuchs; Richard K Sterling; Arun J Sanyal; Puneet Puri; Mohammad S Siddiqui; Richard T Stravitz; Iliana Bouneva; Velimir Luketic; Nicole Noble; Melanie B White; Pamela Monteith; Ariel Unser; James B Wade
Journal:  Hepatology       Date:  2013-05-23       Impact factor: 17.425

10.  Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy.

Authors:  F J Torlot; M J W McPhail; S D Taylor-Robinson
Journal:  Aliment Pharmacol Ther       Date:  2013-01-07       Impact factor: 8.171

View more
  10 in total

1.  Canadian regulations and legal ramifications for hepatic encephalopathy: a descriptive analysis.

Authors:  Henry H Nguyen; Mark G Swain; Philip Wong; Stephen E Congly
Journal:  CMAJ Open       Date:  2018-12-03

2.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

3.  Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.

Authors:  Sanath Allampati; Andres Duarte-Rojo; Leroy R Thacker; Kavish R Patidar; Melanie B White; Jagpal S Klair; Binu John; Douglas M Heuman; James B Wade; Christopher Flud; Robert O'Shea; Edith A Gavis; Ariel B Unser; Jasmohan S Bajaj
Journal:  Am J Gastroenterol       Date:  2015-12-08       Impact factor: 10.864

4.  Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.

Authors:  Sahaj Rathi; Madhu Chopra; Gourdas Chouduri; Praveen Sharma; Kaushal Madan; Mohinish Chhabra; Ramesh R Rai; Anurag Govil; Asokananda Konar; Mahesh Goenka; Manoj Agarwal; Jayanta Mukherjee; Vinay Thorat; Sanjay Salunkhe; Philip Abraham; Aabha Nagral; Ajay Jhaveri; Naresh Bhat; Joy Varghese; Arun R S; Deevaguntla C Reddy; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2018-10-15

5.  Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients.

Authors:  Mahmoud A Osman; Moataz M Sayed; Khaled A Mansour; Shereen A Saleh; Wesam A Ibrahim; Sara M Abdelhakam; Mohamed Bahaa; Wael A Yousry; Hosam S Elbaz; Reginia N Mikhail; Azza M Hassan; Ehab H Elsayed; Dalia A Mahmoud
Journal:  World J Hepatol       Date:  2016-10-28

6.  Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction.

Authors:  Ji Heun Jeong; Do Kyung Kim; Nam-Seob Lee; Young-Gil Jeong; Ho Won Kim; Jong-Seok Kim; Seung-Yun Han
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

7.  Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study.

Authors:  Helen Vidot; Erin Cvejic; Liam J Finegan; E Arthur Shores; David G Bowen; Simone I Strasser; Geoffrey W McCaughan; Sharon Carey; Margaret Allman-Farinelli; Nicholas A Shackel
Journal:  Nutrients       Date:  2019-08-06       Impact factor: 5.717

8.  Do Triphasic Waves and Nonconvulsive Status Epilepticus Arise From Similar Mechanisms? A Computational Model.

Authors:  Sophie Ligtenstein; Jiangling Song; Jin Jin; Haoqi Sun; Luis Paixao; Sahar Zafar; M Brandon Westover
Journal:  J Clin Neurophysiol       Date:  2021-09-01       Impact factor: 2.590

9.  SOFA in the first 24 hours as an outcome predictor of acute liver failure.

Authors:  Edison Moraes Rodrigues-Filho; Rogério Fernandes; Anderson Garcez
Journal:  Rev Bras Ter Intensiva       Date:  2018-03

10.  Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.

Authors:  Charlotte W Wernberg; Ove B Schaffalitzky de Muckadell; Hendrik Vilstrup; Mette M Lauridsen
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.